ResearchMoz.us

ResearchMoz is the one stop online destination to find and buy market research reports and Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Showing posts with label Espicom's Report. Show all posts
Showing posts with label Espicom's Report. Show all posts

Wednesday, 22 January 2014

Generic Drugs: Global collaboration opportunities | Researchmoz

Posted on 23:16 by Unknown
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.


At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of branded medicines have made moves to increase generic prescribing.

But pressure on health spending is seeing downward pressure on generic prices. With lower margins this is creating pain for generics companies.

SME Generic companies offer focused opportunities

With established markets compromised, where can the industry go? Expansion in the sector has been seen through more partnering, either through outright acquisition to increase market share or through product and marketing licensing. Being bigger and having improved market access is seen as a way of distributing cost and strengthening revenues. While major players such as Teva and Sandoz play an international role, there are a number of established and progressive generic manufacturers worthy of consideration.

Browse All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html

Table of Content

Companies In This Report.1
Company Details In Focus.8

ArgentInA.17
Laboratorios Phoenix.17
Snapshot .17
Background.17
Products .17
Major Developments.17
Contact Details.18

AuStrAlIA.19
Alchemia.19
Snapshot .19
Background.19
Products .19
Financials .20
Major Developments.20
Contact Details.21


BAnglADeSh.22
Beximco Pharmaceuticals.22
Snapshot .22
Background.22
Products .22
Financials .23
Major Developments.23
Contact Details.24

About Us

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis.We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports.We provide our services to all sizes of organizations and across all industry verticals and markets.Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.


Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Posted in | No comments

Tuesday, 12 November 2013

Medical Device Market: Belgium, Malaysia, Bulgaria, Netherlands : Researchmoz.us

Posted on 02:35 by Unknown
ResearchMoz.us include new market research report"Medical Device Market: Belgium, Malaysia, Bulgaria, Netherlands " to its huge collection of research reports.


Belgium Medical Device Market 

Belgium’s six-party coalition government under the premiership of Elio Di Rupo has entered its second year. Major differences over the devolution of power to the regional governments and taxation issues hampered the formation of a new government after the general election in June 2010. The wealthier Flemish community has long campaigned for healthcare to be funded separately by the regions on the basis that Flanders is subsidising over-consumption in the francophone community.


Healthcare provision is generally good and of high quality, although there is still an over-reliance on hospital services, two thirds of which are provided by the private sector. Efforts are focusing on improving access to care for chronically-ill patients in general, and on improving the level of care for key patient groups by promoting a more co-ordinated approach between GPs and specialists.

Malaysia Medical Device Market

Malaysia’s first set of regulations for medical devices, the Medical Devices Act 2012 (Act 737), was approved in March 2012. Effective November 2012, it became mandatory for all medical devices to be registered with the Medical Devices Authority (MDA). The regulations are aligned with the guidelines drawn up by the ASEAN Harmonisation Working Party (AHWP) and the Global Harmonisation Work Force (GHTF).


The major natural resource is rubber, and the country’s medical device exports are dominated by latex products such as surgical gloves. The share of this sub-category has slowly started to diminish with the steady growth of diagnostic imaging exports in recent years, particularly electrocardiographs and other electrodiagnostic apparatus.

Bulgaria Medical Device Market

Bulgaria is located in south-eastern Europe, bordering Romania, Serbia, Macedonia, Greece and Turkey and is one of the newest members of the EU, joining in January 2007, alongside Romania. The population of Bulgaria is estimated at 7.3 million in 2013, 18.4% of whom are aged 65 or over. The Prime Minister of Bulgaria is Boyko Borissov, leader of the GERB and former major of Sofia. The current president is Rosen Plevneliev, who took office in January 2012.


In 2013, the Bulgarian market for medical equipment and supplies is estimated at US$225.9 million, or US $30.7 per capita. This is a marked reduction when compared with 2007 and 2008, largely due to lower spending on capital items. A slow but unspectacular recovery should take the market to US$274.1 million by 2018.

Netherlands Medical Device Market

The Netherlands has a long history of providing accessible healthcare, although resources are comparatively low for a Western European country. A mandatory health insurance scheme was introduced in January 2006. This replaced the previous two-tier system and provides basic health insurance cover for acute care services with a separate scheme for long term medical care. The new health insurance act has substantially increased price competition amongst insurers and healthcare providers resulting in one of the most market-oriented healthcare systems in Europe.


The economic downturn, which resulted in a 1.1% contraction in the economy in 2012, has further increased financial pressures on the health service, which ran up sizeable deficits in 2009 and 2010. In July 2013, the Health Ministry agreed a package of measures with healthcare providers to cut EUR1.0bn from forecast healthcare spending as part of the government's proposed EUR 6.0bn austerity programme. 

Browse All Espicom Market Research Reports @ http://www.researchmoz.us/publisher/espicom-60.html

For More Information Kindly Contact:
Email: sales@researchmoz.us 
Posted in | No comments

Tuesday, 24 September 2013

Latest Research On Advances in the Obesity Market Research Report Available On ResearchMoz

Posted on 22:02 by Unknown
ResearchMoz.us include new market research report" Advances in the Obesity Market" to its huge collection of research reports.

This report reviews the current state of the obesity market for both pharmaceuticals and medical devices, examining why the obesity market is of such importance across established and emerging economies and how current interventions measure up.


In July 2011, the American Association of Clinical Endocrinologists (AACE) reclassified obesity as a diseased state, not a condition, in order to move it up the US healthcare agenda. In 2012, the FDA reviewed its stance on anti-obesity products and approved two new products that were previously declined.

As it stands, there are over 40 medicines currently approved or used off label to treat obesity, in addition there are more than 20 innovative products in clinical development. This new report examines the latest products and devices in development and compares them to those currently available, gathering opinions from key industry leaders to highlight the fast-moving changes that are affecting this profit potential market.

This report provides you with a detailed analysis and key opinions on the current and future obesity market...

Detailed review of the current obesity market, answering ‘Where are we now?’ for both established and emerging economies
Comprehensive insight into newly approved pharmaceuticals and medical devices, analysing how they compare to established brands
Assessment of key products and devices in development, identifying ‘Ones to Watch’ in late-stage clinical development
Reviews of products and devices that are ‘Waiting in the Wings’ in early-stage clinical development where PoC data is being gathered
Analyses of potential ‘Long Shots’ representing new and innovative products where the rationale has yet to be fully tested.

This report provides a comprehensive overview of existing anti-obesity therapies and surgical interventions. It provides a systematic appraisal of each market segment highlighting both the leading players and new entrants. The report includes thoughts from key opinion leaders across the globe to find out where the key challenges and opportunities exist for both pharma and medical device manufacturers. 

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

For More Information Kindly Contact:
Posted in | No comments
Subscribe to: Posts (Atom)